Our sphingomyelin syntase (SMS) 2 mouse studies indicated that SM biosynthesis is responsible for NF-κB and MAP kinase-mediated inflammatory and atherosclerosis [18,19]. The gene discussed is NFKB1; the disease is atherosclerosis.